Head-to-head · computed 2026-08-11
MEDVi vs Zealthy
MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat. Zealthy: Zealthy pairs a $135/month membership with compounded medication sold separately or in bundles: all-in ongoing costs run about $297/month semaglutide and $449/month tirzepatide bundled, or about $286 and $351 on three-month-supply pricing once the membership is counted.
Tirzepatide
| MEDVi | Zealthy | |
|---|---|---|
| All-in maintenance | $399/mo | $449/mo |
| Best plan rate | $399/mo | $351/mo |
| 12-month total | $4,788 | $5,388 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, MEDVi's $399 a month undercuts Zealthy's $449 by $50 a month at the 10 mg/wk maintenance basis — $600 across a year. MEDVi's figure is provider-stated (captured 2026-08-05) and Zealthy's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
MEDVi's tirzepatide ladder runs $399 a month billed monthly. Zealthy's runs $449 a month billed monthly, and $351 a month on a three-month plan. On the twelve-month basis MEDVi's $4,788 beats Zealthy's $5,388 by $600 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| MEDVi | Zealthy | |
|---|---|---|
| All-in maintenance | $299/mo | $297/mo |
| Best plan rate | $299/mo | $286/mo |
| 12-month total | $3,588 | $3,564 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Zealthy's $297 a month undercuts MEDVi's $299 by $2 a month at the 2.4 mg/wk maintenance basis — $24 across a year. Zealthy's figure is reported (captured 2026-08-11) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
MEDVi's semaglutide ladder runs $299 a month billed monthly. Zealthy's runs $297 a month billed monthly, and $286 a month on a three-month plan. On the twelve-month basis Zealthy's $3,564 beats MEDVi's $3,588 by $24 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
MEDVi carries no membership fee against Zealthy's $135 a month — $1,620 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, MEDVi is dose-flat — the price survives titration — while Zealthy's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. On verifiability, MEDVi names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Zealthy's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice.
Structure, side by side
MEDVi
- MembershipNone
- Dose policyTiered on semaglutide; tirzepatide flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
Zealthy
- Membership$135/mo
- Dose policyNot stated on captured materials
- CommitmentMonthly membership; medication discounts require 3-month supply purchases
- CancellationPer published terms; membership and medication bill separately on unbundled plans — confirm both at checkout
- PharmacyPartner compounding pharmacies (NABP-accredited and LegitScript-certified per co
What our desk is watching on each
MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Zealthy: The advertised $151 (semaglutide) and $216 (tirzepatide) figures are three-month-supply medication-only rates that exclude the $135 monthly membership — the canonical case for this site's all-in accounting. Bundled ongoing rates: $297/mo semaglutide, $449/mo tirzepatide after discounted first months ($217/$349). Brand-name pens run ~$1,349 cash through the platform. Reported from third-party reviews and Zealthy's own pricing page; our checkout capture is pending.
Questions people ask
Is MEDVi or Zealthy cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does MEDVi vs Zealthy miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do MEDVi and Zealthy cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,788 at MEDVi and $5,388 at Zealthy — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: MEDVi · Zealthy. Official sites: MEDVi ↗ · Zealthy ↗. Nothing here is medical advice.